Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxyprogesterone acetate and 5 mg of E 2 -cypionate: effects on ovarian function

By Petta C.A.   Hays M.   Brache V.   Massai R.   Hua Y.   Alvarez-Sanchez F.   Croxatto H.   d'Arcangues C.   Cook L.A.   Bahamondes L.  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 744-748

Elsevier

Access to resources Recommend Favorite

Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?

By MacLennan Alastair   Sturdee David  

Climacteric, Vol. 9, Iss. 5, 2006-10 ,pp. : 321-322

Informa Healthcare

Access to resources Recommend Favorite

The long-term effectiveness of endometrial laser ablation: a survival analysis

By Shankar M.   Naftalin N.J.   Taub N.   Habiba M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 108, Iss. 1, 2003-05 ,pp. : 75-79

Elsevier

Access to resources Recommend Favorite

Long-term endometrial and breast safety of a specific, standardized soy extract

By Palacios S.   Pornel B.   Vázquez F.   Aubert L.   Chantre P.   Marès P.  

Climacteric, Vol. 13, Iss. 4, 2010-08 ,pp. : 368-375

Informa Healthcare

Access to resources Recommend Favorite

Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?

By Özalp S.   Kabukcuoglu S.   Tanir H. M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 1, 2003-03 ,pp. : 17-20

Informa Healthcare

Access to resources Recommend Favorite